Please login to the form below
voclosporin
This page shows the latest voclosporin news and features for those working in and with pharma, biotech and healthcare.
Lupus trial hailed as a success despite patient deaths
Phase IIb trial of Aurinia Pharmaceuticals’ voclosporin met its objective. A medical charity representing patients with lupus erythematosus has welcomed the results of a study showing the efficacy of a new ... The phase IIb trial of Aurinia
Latest news
-
Scratching the surface
The ESSENCE and SPIRIT trials have been completed for Isotechnika's voclosporin, a calcineurin inhibitor and oral immunosuppressant. ... The likelihood of voclosporin gaining approval is 58 per cent, according to inThought analysts.
More from news
Approximately 1 fully matching, plus 1 partially matching documents found.
Latest appointments
-
Bayer veteran joins Aurinia as CEO
Aurinia is well positioned to bring voclosporin forward as an important new treatment for lupus nephritis,” he said. ... companies. “He is exceptionally qualified to help us build our voclosporin franchise and sharpen our execution.".
More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- How will the events and exhibitions industry change post-Coronavirus?
- New study identifies drugs that are safe to use in COVID-19 treatment
- Keytruda doubles five-year survival rate in NSCLC
- Novavax starts first phase 3 COVID-19 vaccine trial in the UK
- Novacyt launches diagnostic test to differentiate between COVID-19 and flu
- Relief Therapeutics seeks US emergency approval for COVID-19 drug
PMHub
EPG Health
REACH, ENGAGE & MEASURE - Accomplish meaningful HCP engagement via Medthority, our trusted independent medical website. Support education and treatment...
Latest intelligence
- Switzerland: a life sciences hub
- Switzerland has a rich diversity of pharma and biotech companies that sustain activity and help maintain its reputation as a highly innovative country...
- Responding to dynamic shifts in value communications
- OPEN Health’s Beth Lesher and Annemarie Clegg examine what the convergence of medical communications and market access means for pharmaceutical companies....
- Doing what we can and having fun doing it: our fundraising month
- Charities are facing a number of challenges just to stay afloat amidst the current COVID-19 pandemic. Fundraisers are being cancelled and public donations are not as abundant as they have...
Quick links
Infographics
